AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26580866
Drug: FELR and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FELR and topical agents alone
Trial: 20502135
Drug: Multidrug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug therapy
Trial: 17184146
Drug: Fenofibrate treatment
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenofibrate treatment for three months
Trial: 9135178
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural analgesia with bupivacaine 0.5% followed by bupivacaine 0.375% infusion
Trial: 12665489
Drug: Statin pretreatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin pretreatment in patients with hsCRP > or =1.11 mg/dL
Trial: 10388979
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion (2.4 pmol.kg‐1.min‐1)
Trial: 24170152
Drug: Pulse irrigation
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse irrigation with 2 L normal saline (<15 psi)
Trial: 24170152
Drug: Standard irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard irrigation with 2 L normal saline poured into the wound
Trial: 22451437
Drug: WHEY (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHEY (25 g of whey protein)
Trial: 20050300
Drug: Electroacupuncture applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electroacupuncture applied to acupuncture points PC6 and HT7 for 20 minutes twice a week for 8 weeks
Trial: 11286433
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose pergolide
Trial: 11286433
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose pergolide
Trial: 2896359
Drug: Zuclopenthixol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zuclopenthixol (4 mg daily, increased if necessary over 4 weeks)
Trial: 30928088
Drug: Concurrent control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent control group (Blacks 83.1% vs. Whites 90.1%, p < 0.001).
Trial: 30928088
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group compared to concurrent control for Blacks.
Trial: 26738450
Drug: Topical DLX105
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical DLX105 (0.5% hydrogel formulation)
Trial: 25074252
Drug: Aspirin reload
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin reload (325 mg orally)
Trial: 22815989
Drug: Polypill (amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypill (amlodipine 2.5 mg, losartan 25 mg, hydrochlorothiazide 12.5 mg, simvastatin 40 mg)
Trial: 19717646
Drug: Ketoprofen (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (300 mg/day for 5 days)
Trial: 17300594
Drug: Sitagliptin 50
RxNorm normalized name: SITagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 50 mg twice daily (b.i.d.)
Trial: 15144392
Drug: 20% ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% ALA preparation in Eucerin cream applied under an occlusive dressing followed by irradiation with 75 J/cm² of broad-band red light.
Trial: 11176160
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) therapy
Trial: 8567093
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 200 mg/week
Trial: 8567093
Drug: Control (baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (baseline measurements before injections)
Trial: 19300425
Drug: L-arginine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (3 x 7 g/day)
Trial: 1933601
Drug: Intranasal calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal calcitonin (200 IU) plus calcium (500 mg) daily for 3 years or 4 years
Trial: 1933601
Drug: Intranasal calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal calcitonin (200 IU) plus calcium (500 mg) daily for 3 years
Trial: 1933601
Drug: Intranasal calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal calcitonin (200 IU) plus calcium (500 mg) daily for 2 years
Trial: 319936
Drug: Fenfluramine, 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine, 120 mg/day for 10 or more days
Trial: 28426239
Drug: Usual insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual insulin pump + continuous glucose monitor (CGM) care at home
Trial: 25354554
Drug: Interaction between
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interaction between chemotherapy and genotype
Trial: 23821768
Drug: Risperidone or
RxNorm normalized name: risperidone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone or olanzapine dose reduction (50% in 4 weeks, maintained thereafter)
Trial: 25099201
Drug: Maintenance group
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance group (dose kept constant)
Trial: 1514532
Drug: Calcium chloride
RxNorm normalized name: Calcium Chloride
DrugBank: Calcium chloride (DB01164)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium chloride administration
Trial: 6151503
Drug: Antihypertensive regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive regimens containing a beta-blocker (oxprenolol)
Trial: 6151503
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy not containing a beta-blocker
Trial: 29061540
Drug: Suspicious digital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspicious digital rectal examination
Trial: 27569432
Drug: Abnormal prostate
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abnormal prostate specific antigen (4 ng/ml or greater)
Trial: 27569432
Drug: Suspicious digital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspicious digital rectal examination and abnormal prostate specific antigen (combined)
Trial: 10732848
Drug: HMG-CoA reductase
RxNorm normalized name: HMG-CoA reductase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG-CoA reductase inhibitor (simvastatin)
Trial: 26749408
Drug: Apixaban 10
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban 10 mg orally
Trial: 26749408
Drug: Rifampin 600
RxNorm normalized name: rifampin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin 600 mg once daily
Trial: 22201295
Drug: Flucloxacillin 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin 2 g (5-minute infusion)
Trial: 20063994
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg misoprostol 3‐hourly (group A)
Trial: 20063994
Drug: 600 microg
RxNorm normalized name: Fentanyl 600 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 microg misoprostol 6‐hourly (group B)
Trial: 20063994
Drug: 800 microg
RxNorm normalized name: Fentanyl 800 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 microg misoprostol 12‐hourly (group C)
Trial: 17727927
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by radical surgery
Trial: 17727927
Drug: Various drug
RxNorm normalized name: VARIOUS DRUG CLASSES IN ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various drug regimens for neoadjuvant chemotherapy
Trial: 12693427
Drug: Amisulpride (50-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (50-300 mg daily)
Trial: 7591492
Drug: Standard weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard weekly intervention (6 weekly sessions)
Trial: 6754634
Drug: Non-treatment (control)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment (control)
Trial: 28345400
Drug: A‐mix (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A‐mix (3 g/dose)
Trial: 25496283
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care family therapy (UC-FT)
Trial: 8425702
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg captopril
Trial: 3118827
Drug: TPN supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPN supplemented with ornithine‐alpha‐ketoglutarate (0.35 g/kg bw/day)
Trial: 31747326
Drug: EGCG (440
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG (440 μM) administered at first onset of ARIE and then weekly after final radiotherapy
Trial: 31747326
Drug: EGCG (440
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG (440 μM) administered for ARIE
Trial: 30112772
Drug: Mirabegron 50
RxNorm normalized name: mirabegron 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron 50 mg as first-line treatment
Trial: 30112772
Drug: Tolterodine 4
RxNorm normalized name: tolterodine 4 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 4 mg as first-line treatment
Trial: 18394501
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group TRP(8)
Trial: 18394501
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group TRP(30)
Trial: 17109664
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25-1 mg daily
Trial: 12891539
Drug: Oral tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tacrolimus 0.2 mg. kg(‐1). day(‐1)
Trial: 10492065
Drug: Vincristine, Prednisone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincristine, Prednisone, and L-asparaginase (VPL)
Trial: 8731073
Drug: Low‐dose artificial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐dose artificial light (0.5 h@2800 lux)
Trial: 8731073
Drug: Natural light
RxNorm normalized name: OCTINOXATE 138 mg in 4 mL / TITANIUM DIOXIDE 123 mg in 4 mL TOPICAL CREAM [SHISEIDO WHITE LUCENT ONMAKEUP SPOT CORRECTING SERUM NATURAL LIGHT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural light treatment (1‐h morning walk outdoors)
Trial: 1836687
Drug: 3 chemotherapeutic
RxNorm normalized name: Other chemotherapeutics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 chemotherapeutic regimens at 3-monthly intervals
Trial: 22316141
Drug: 6-weekly group-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-weekly group-based skills training for adolescents followed by 6-weekly targeted newsletters for caregivers (Group 1)
Trial: 12716275
Drug: Selective Serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Serotonin Reuptake Inhibitors (SSRIs) (N = 749)
Trial: 23021480
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (P-ESDM and community treatment)
Trial: 3139279
Drug: leutinizing hormone‐releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: leutinizing hormone‐releasing hormone (LHRH) analog buserelin
Trial: 21098692
Drug: Extended-release hydromorphone
RxNorm normalized name: hydromorphone Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release hydromorphone 16 mg after a high-fat breakfast
Trial: 21098692
Drug: Immediate-release hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release hydromorphone 16 mg daily dose (4 mg qid) in the fasted state
Trial: 19408811
Drug: Calcium pre-rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium pre-rinse (150 mmol/L)
Trial: 3513009
Drug: Unchanged conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unchanged conventional treatment
Trial: 23390778
Drug: Original clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original clopidogrel 600 mg
Trial: 23390778
Drug: Generic clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic clopidogrel 600 mg
Trial: 18284648
Drug: Renzapride 1
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 1 mg/day
Trial: 18284648
Drug: Renzapride 2
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 2 mg/day
Trial: 18284648
Drug: Renzapride 4
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 4 mg/day (women)
Trial: 15625258
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia alone or in combination with placebo blocks
Trial: 12895220
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy with tetracycline
Trial: 12895220
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy with metronidazole
Trial: 12895220
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy with metronidazole (with metronidazole resistance)
Trial: 8351363
Drug: Lytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lytic therapy (both FI and CI)
Trial: 19266381
Drug: Viagra plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viagra plus sex therapy (VST)
Trial: 15454133
Drug: Robotic telerounding
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic telerounding (substitution of one daily bedside round with a robotic telerounding visit)
Trial: 15454133
Drug: Standard once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard once-daily attending bedside rounds
Trial: 8391282
Drug: Clindamycin 300
RxNorm normalized name: clindamycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 300 mg
Trial: 7599015
Drug: Clindamycin 600
RxNorm normalized name: clindamycin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 600 mg
Trial: 12679215
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg (Black patients)
Trial: 12679215
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg (Black patients)
Trial: 12679215
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg (White patients)
Trial: 12679215
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg (White patients)
Trial: 30787343
Drug: d[Ca] 1.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d[Ca] 1.75 mmol/L
Trial: 30787343
Drug: d[Ca] 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d[Ca] 1.25 mmol/L
Trial: 28893387
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care + Pulsed Electromagnetic Frequency (PEMF) therapy
Trial: 25425475
Drug: Denosumab 120
RxNorm normalized name: DENOSUMAB 120 MG/1.7 ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 120 mg subcutaneously every 4 weeks (Q4W)
Trial: 19176543
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg asoprisnil daily for 12 weeks
Trial: 19176543
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg asoprisnil daily for 12 weeks
Trial: 17534812
Drug: Intravenous sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sedation
Trial: 9674466
Drug: Flutter treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutter treatment
Trial: 8592286
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy and continuous passive motion (n = 21)
Trial: 8592286
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy only (n = 18)
Trial: 2228322
Drug: sulglycotide (oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulglycotide (oral, 200 mg t.i.d. for 6 weeks, n = 93)
Trial: 346631
Drug: 50% lactulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% lactulose syrup
Trial: 27899298
Drug: 4% menthol
RxNorm normalized name: LEVOMENTHOL 0.04 mg in 1 mL TOPICAL GEL [Auvon 4% Menthol Pain Relief Gel]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% menthol gel (0.017mL·cm‐2)
Trial: 26497109
Drug: Fluticasone furoate/vilanterole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterole (FF/VI) 200/25 μg
Trial: 9041463
Drug: High-dose IFN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IFN
Trial: 17614242
Drug: Brief family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief family treatment (BFT)
Trial: 17614242
Drug: Continuing care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing care (regardless of treatment condition)
Trial: 12616666
Drug: Dispersible tablets
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible tablets of everolimus (0.8 mg/m2, maximum 1.5 mg, bid)
Trial: 12616666
Drug: Dispersible tablets
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible tablets of everolimus (1.5 mg) after a high-fat meal
Trial: 12616666
Drug: Conventional tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional tablets of everolimus (1.5 mg)
Trial: 9026479
Drug: Loxiglumide infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loxiglumide infusion
Trial: 6370811
Drug: Flunarizine 10
RxNorm normalized name: flunarizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 10 mg daily
Trial: 3903501
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy combined with chemotherapy
Trial: 30376687
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy alone
Trial: 17519730
Drug: Midazolam bolus
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam bolus of 0.05 mg/kg plus continuous infusion 0.08 mg/kg per hour (both groups)
Trial: 9739441
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (CMF)
Trial: 9739441
Drug: Temporary ovarian
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temporary ovarian ablation by treatment with a LHRH analogue (Zoladex, Goserlin)
Trial: 21822145
Drug: SL65.0472‐00 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SL65.0472‐00 (20 mg)
Trial: 21822145
Drug: Sumatriptan (agonist)
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sumatriptan (agonist)
Trial: 17717114
Drug: Quercetin (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (1,000 mg/day)
Trial: 8633188
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg lithium carbonate
Trial: 8633188
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lithium carbonate
Trial: 22681960
Drug: Oral lansoprazole
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral lansoprazole
Trial: 15545311
Drug: MP (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP (100 mg)
Trial: 11684534
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (105 mg/d)
Trial: 11684534
Drug: High-iron diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-iron diet (2.25 mg/d)
Trial: 2509120
Drug: Indomethacin treatment
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin treatment for the first six postoperative weeks
Trial: 2509120
Drug: No anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anti-inflammatory treatment (Control)
Trial: 775991
Drug: Contraceptive medication
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive medication